Final results of a placebo-controlled study of filgrastim in small-cell lung cancer: exploration of risk factors for febrile neutropenia.

Source:http://linkedlifedata.com/resource/pubmed/id/18632435

Support Cancer Ther 2005 Oct 1 3 1 36-46

Download in:

View as

General Info

PMID
18632435